...
首页> 外文期刊>American Journal of Physiology >Regulation of ET-1 biosynthesis in cerebral microvascular endothelial cells by vasoactive agents and PKC.
【24h】

Regulation of ET-1 biosynthesis in cerebral microvascular endothelial cells by vasoactive agents and PKC.

机译:血管活性剂和PKC对脑微血管内皮细胞ET-1生物合成的调节。

获取原文
获取原文并翻译 | 示例

摘要

Endothelin-1 (ET-1) is the most potent vasoconstrictor agent known. ET-1 is elevated in the cerebrospinal fluid following hemorrhage and brain injury and can compromise cerebral microvascular homeostasis. The modulation of ET-1 production by cerebral microvascular endothelial cells and the mechanism by which such changes take place are very important in our understanding of the pathological roles of ET-1. In the present study, we investigated the effects of vasoconstrictor agents that can be released from hemolyzed blood, cAMP-dependent dilators, and the role of protein kinase C (PKC) in the regulation of ET-1 production by piglet cerebral microvascular endothelial cells in culture. ET-1 was measured by RIA. 1) Cerebral microvascular endothelial cells synthesize and release ET-1 into the media; 2) 5-hydroxytryptamine (5-HT), lysophosphatidic acid (LPA), thromboxane analog U-46619, fetal bovine serum (20%), and phorbol 12-myristate 13-acetate significantly increase ET-1 production; 3) basal and vasoconstrictor agent-induced increases in ET-1 production by endothelial cells may be mediated via PKC; 4) cAMP-dependent vasodilators attenuate the basal production of ET-1 by cerebral microvessels; and 5) pretreatment of endothelial cells with a higher concentration of LPA, U-46619, or 5-HT counterbalances the cAMP-dependent dilator agent-induced reduction in basal ET-1 production. Therefore, by-products of hemolyzed blood can stimulate the production of ET-1 by a PKC-mediated mechanism. cAMP-dependent dilators can attenuate the vasoconstrictor agent-induced elevation in ET-1 production. These results suggest that cerebral microvascular homeostasis could be compromised by effects of interactions among vasoactive agents released during conditions injurious to the brain and they may further the understanding of potential contributions of hemolyzed blood clots to subarachnoid hemorrhage-induced vasospasm.
机译:内皮素-1(ET-1)是已知的最有效的血管收缩药。出血和脑损伤后,脑脊液中的ET-1升高,可损害脑微血管动态平衡。脑微血管内皮细胞对ET-1产生的调节作用以及发生这种变化的机制,对于我们对ET-1的病理作用的理解非常重要。在本研究中,我们研究了可从溶血中释放的血管收缩剂,依赖cAMP的扩张剂的作用以及蛋白激酶C(PKC)在调节仔猪脑微血管内皮细胞ET-1产生中的作用。文化。 ET-1通过RIA测量。 1)大脑微血管内皮细胞合成并释放ET-1到培养基中; 2)5-羟色胺(5-HT),溶血磷脂酸(LPA),血栓烷类似物U-46619,胎牛血清(20%)和佛波醇12-肉豆蔻酸酯13-乙酸酯显着增加了ET-1的产生; 3)基底细胞和血管收缩剂诱导的内皮细胞ET-1产量增加可能是通过PKC介导的; 4)依赖cAMP的血管扩张剂减弱了脑微血管对ET-1的基础产生; 5)用较高浓度的LPA,U-46619或5-HT预处理内皮细胞可抵消cAMP依赖的扩张剂引起的基础ET-1产生的减少。因此,溶血血液的副产物可以通过PKC介导的机制刺激ET-1的产生。 cAMP依赖的扩张剂可以减弱血管收缩剂诱导的ET-1产生的升高。这些结果表明,脑微血管动态平衡可能会受到伤害大脑的条件下释放的血管活性剂之间相互作用的影响而受损,它们可能会进一步了解溶血的血凝块对蛛网膜下腔出血引起的血管痉挛的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号